Northland Securities Initiates Coverage on Luminex (LMNX) with an Outperform

May 29, 2009 12:56 PM EDT

Northland Securities initiates coverage on Luminex (Nasdaq: LMNX) with an Outperform. Price target $19.25.

To see more analyst ratings on LMNX Click Here.

Luminex Corporation develops, manufactures and sells biological testing technologies and products with applications throughout the life sciences and diagnostic industries.


Related Categories

New Coverage

Stocks Mentioned

LMNX 14.59

+0.31 +2.17%
Volume: 395,266
Track LMNX


Related Entities


Add Your Comment